Long Island Jewish Medical Center is a clinical and academic hospital within the Northwell Health system. It is a 583-bed, non-profit tertiary care teaching hospital serving the greater New York metropolitan area.

There are 583 beds in Long Island Jewish Medical Center.

During the past decade, Long Island Jewish Medical Center conducted 128 clinical trials. In the 10-year time frame, 128 clinical trials started and 153 clinical trials were completed, i.e. on average, 119.5% percent of trials that started reached the finish line to date. In the past 5 years, 67 clinical trials started and 67 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Long Island Jewish Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 51 trials, followed by "Northwell Health" with 46 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored, "Radiation Therapy Oncology Group" with 14 trials sponsored and "Vertex Pharmaceuticals Incorporated" with 14 trials sponsored. Other sponsors include 223 different institutions and companies that sponsored additional 135 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Long Island Jewish Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 78 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator and "NCIC Clinical Trials Group" with 9 trials as a collaborator. Other collaborators include 282 different institutions and companies that were collaborators in the rest 199 trials.

According to Clinical.Site data, the most researched conditions in "Long Island Jewish Medical Center" are "Cystic Fibrosis" (20 trials), "Leukemia" (17 trials), "Chronic Lymphocytic Leukemia" (15 trials), "Breast Cancer" (14 trials) and "HIV Infections" (12 trials). Many other conditions were trialed in "Long Island Jewish Medical Center" in a lesser frequency.

Most popular intervention types in "Long Island Jewish Medical Center" are "Drug" (257 trials), "Other" (101 trials), "Biological" (55 trials), "Procedure" (37 trials) and "Radiation" (32 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (45 trials), "Placebo" (33 trials), "Quality-of-Life Assessment" (26 trials), "Paclitaxel" (20 trials) and "Carboplatin" (14 trials). Other intervention names were less common.

The vast majority of trials in "Long Island Jewish Medical Center" are 313 trials for "All" genders, 56 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 96 active trials in "Long Island Jewish Medical Center". 1 are not yet recruiting, 33 are recruiting, 57 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 221 completed trials in Long Island Jewish Medical Center, 5 suspended trials, and 45 terminated clinical trials to date.

Out of the total trials that were conducted in Long Island Jewish Medical Center, 20 "Phase 1" clinical trials were conducted, 114 "Phase 2" clinical trials and 141 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 47 trials that are defined as “Not Applicable".